External Collaborative Research Grants

Funder: Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) - BI Cares Foundation

The External Collaborative Research Grants by Boehringer Ingelheim support academic and clinical scientists in proposing research studies. These grants facilitate collaboration with Boehringer Ingelheim, which may provide intellectual and financial support. Applicants must assume full responsibility for their research while complying with regulatory standards. The funding should cover research costs, excluding salary support for the collaborative partner. Interested investigators must apply online for consideration.

Background
The Boehringer lngelheim ECR Program is offered to academic and clinical scientists, who are interested in proposing a research study and wish to collaborate with Boehringer lngelheim - as the supportive partner - to further develop a protocol and analyze and/or publish the results. In addition to providing intellectual contributions, Boehringer lngelheim may provide drug and/or financial support to an approved ECR.
The collaborative partner must assume all responsibility (including under applicable regulations) and retain ultimate control over the conduct of the ECR including acting as a regulatory sponsor.
Boehringer lngelheim does not serve as the regulatory sponsor for ECR.
The budget for such studies should reflect the funding required to conduct the research (e.g. actual costs of materials and services) and cannot include direct salary support of the collaborative partner.
Boehringer lngelheim requires investigators to apply for support via an online application process.

Eligibility

Clinical Research Grant applications are offered to all qualified academic and community based scientists or consortia who are interested in independently proposing and conducting their own research.Grant proposals for Investigator Initiated Studies (IIS) and External Collaborative Research (ECR) are accepted.